HRT Financial’s Colgate-Palmolive CL Stock Holding History

HRT Financial’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-8,403	Closed	-$597K	–	2398
2023 Q3	$597K	Sell	8,403 -102,944	-92%	-$7.7M	0.01%	1302
2023 Q2	$8.58M	Sell	111,347 -19,076	-15%	-$1.48M	0.08%	175
2023 Q1	$9.8M	Buy	130,423 +103,136	+378%	+$7.67M	0.12%	138
2022 Q4	$2.15M	Buy	+27,287	New	+$2.05M	0.03%	556
2022 Q3	–	Sell	-88,735	Closed	-$7.11M	–	2878
2022 Q2	$7.11M	Buy	+88,735	New	+$6.94M	0.08%	186
2021 Q3	–	Sell	-6,870	Closed	-$558K	–	3331
2021 Q2	$558K	Sell	6,870 -31,227	-82%	-$2.55M	0.01%	1656
2021 Q1	$3M	Buy	+38,097	New	+$2.99M	0.03%	433
2020 Q3	–	Sell	-33,126	Closed	-$2.43M	–	1941
2020 Q2	$2.43M	Buy	+33,126	New	+$2.35M	0.07%	291
2019 Q3	–	Sell	-19,779	Closed	-$1.42M	–	1410
2019 Q2	$1.42M	Buy	+19,779	New	+$1.4M	0.09%	220
2019 Q1	–	Sell	-14,804	Closed	-$881K	–	550
2018 Q4	$881K	Buy	+14,804	New	+$926K	0.13%	131

Other funds holding CL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

HRT Financial's CL Position: Q4 2023 in Review

HRT Financial sold out of Colgate-Palmolive (CL) in Q4 2023, closing a stake of 8,403 shares — an estimated $597K sold.

HRT Financial first reported a position in CL in Q4 2018 and held it in 10 quarters. The position peaked at $9.8M in Q1 2023. 1,740 funds tracked by Wall St. Rank hold CL as of Q4 2023.

HRT Financial reported no remaining Colgate-Palmolive position as of Q4 2023 after selling out during the quarter.
HRT Financial sold 8,403 Colgate-Palmolive shares in Q4 2023, an estimated $597K.
HRT Financial first reported a position in Colgate-Palmolive in Q4 2018 and held it in 10 quarters.
HRT Financial's Colgate-Palmolive position peaked at $9.8M in Q1 2023.
1,740 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q4 2023.

Based on HRT Financial's 13F filing for Q4 2023, filed 9 Feb 2024.